Showing results (161-170 of 555) with videos related to
Sort By:
Pageof 56
Matrix Biology : Journal of the International Society for Matrix Biology|November 26, 2009
Collagen XVI induces formation of focal contacts on intestinal myofibroblasts isolated from the normal and inflamed intestinal tractSabine Ratzinger, Johannes A Eble, Anja Pasoldt, et al.Annals of Gastroenterology|November 29, 2023
Concomitant 5-aminosalicylic acid treatment does not affect 6-thioguanine nucleotide levels in patients with inflammatory bowel disease on thiopurinesRahel Looser, Michael Doulberis, Jean-Benoit Rossel, et al.Revue Medicale Suisse|March 16, 2007
[Intestinal inflammatory diseases]Christian Felley, Christian Mottet, Jurg Hess, et al.The American Journal of Gastroenterology|July 4, 2002
Prior bowel resections, perianal disease, and a high initial Crohn's disease activity index are associated with corticosteroid resistance in active Crohn's diseaseCornelia M Gelbmann, Gerhard Rogler, Volker Gross, et al.European Journal of Gastroenterology & Hepatology|June 6, 2014
A distinct pattern of disease-associated single nucleotide polymorphisms in IBD risk genes in a family with Crohn's diseaseChristiane Barthel, Marianne R Spalinger, Jakob Brunner, et al.Journal of Travel Medicine|July 5, 2011
Irritable bowel syndrome among a cohort of European travelers to resource-limited destinationsRaffaela Pitzurra, Michael Fried, Gerhard Rogler, et al.Cold Spring Harbor Molecular Case Studies|May 6, 2016
Long-term changes of bacterial and viral compositions in the intestine of a recovered Clostridium difficile patient after fecal microbiota transplantationFelix Broecker, Jochen Klumpp, Markus Schuppler, et al.Scandinavian Journal of Gastroenterology|August 15, 2014
Analysis of TNF-antagonist switch over time and associated risk factors in the Swiss Inflammatory Bowel Disease CohortPhilippe Hiroz, Stephan R Vavricka, Nicolas Fournier, et al.Case Reports in Gastroenterology|June 3, 2015
New Onset, Aggravation and Recurrence of Crohn's Disease upon Treatment with Three Different Tumor Necrosis Factor InhibitorsJonas Zeitz, Susann Enderlin, Luc Biedermann, et al.Digestion|April 19, 2016
Irinotecan Plus Gemcitabine and Fluorouracil in Advanced Biliary Tract Cancer: A Retrospective StudyEsther Endlicher, Elisabeth Schnoy, Martina Troppmann, et al.Pageof 56